These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4427254)

  • 41. Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS).
    Varma MV; Steyn SJ; Allerton C; El-Kattan AF
    Pharm Res; 2015 Dec; 32(12):3785-802. PubMed ID: 26155985
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Differences in drug pharmacokinetics and effects upon oral versus parenteral administration. Review with special interest in first-pass effect on the liver].
    Morland J
    Tidsskr Nor Laegeforen; 1976 Mar; 96(9-10):554-8. PubMed ID: 1258025
    [No Abstract]   [Full Text] [Related]  

  • 43. [Clinical value of the determination of drugs in the blood: a new aspect of pharmacokinetics].
    Hirtz J; Schoeller JP
    Nouv Presse Med; 1976 Mar; 5(13):869-72. PubMed ID: 1264634
    [No Abstract]   [Full Text] [Related]  

  • 44. Proceedings: Bioavailability and therapeutic efficacy.
    Withey RJ
    Rev Can Biol; 1973; 32():Suppl:21-30. PubMed ID: 4777602
    [No Abstract]   [Full Text] [Related]  

  • 45. [Biologic availability and "1st pass" effect of drugs].
    Rietbrock N; Keller F
    Fortschr Med; 1977 Jul; 95(28):1765-6, 1774-80. PubMed ID: 914146
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bioavailability studies and the clinical pharmacologist: correlation of drug distribution with clinical effects.
    Ogilvie RI
    Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):349-54. PubMed ID: 1099026
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proceedings: Metabolic factors influencing bioavailability.
    Conney AH
    Rev Can Biol; 1973; 32():Suppl:163-70. PubMed ID: 4777600
    [No Abstract]   [Full Text] [Related]  

  • 48. [Absorption and biological availability of drugs].
    Uribe M
    Rev Gastroenterol Mex; 1977; 42(1):2-8. PubMed ID: 616972
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dosage, compliance and bioavailability in perspective.
    Biron P
    Can Med Assoc J; 1976 Jul; 115(2):102-3. PubMed ID: 1277066
    [No Abstract]   [Full Text] [Related]  

  • 50. Route of administration and drug metabolism.
    Gibaldi M; Feldman S
    Eur J Pharmacol; 1972 Sep; 19(3):323-9. PubMed ID: 4640856
    [No Abstract]   [Full Text] [Related]  

  • 51. Comparative bioavailabilities from truncated blood level curves.
    Lovering EG; McGilveray IJ; McMillan I; Tostowaryk W
    J Pharm Sci; 1975 Sep; 64(9):1521-4. PubMed ID: 1185570
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bioavailability of peroral dosage forms.
    Ritschel WA
    Boll Chim Farm; 1973 Mar; 112(3):137-62. PubMed ID: 4198518
    [No Abstract]   [Full Text] [Related]  

  • 53. Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms.
    Akers MJ
    Int J Pharm Compd; 2017; 21(1):47-56. PubMed ID: 28346198
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Letter: Addition of drugs to intravenous fluids.
    Lancet; 1976 Apr; 1(7964):858. PubMed ID: 56671
    [No Abstract]   [Full Text] [Related]  

  • 55. Classical bioavailability methods: blood levels and urinary excretion.
    Dittert LW
    Psychopharmacol Bull; 1976 Oct; 12(4):54-5. PubMed ID: 972991
    [No Abstract]   [Full Text] [Related]  

  • 56. Statistical problems in interpreting comparative bioavailability trials.
    Westlake WJ
    Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):342-5. PubMed ID: 1099025
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The urinary elimination "time lag": determination of the mean residence time from drug accumulation in the urine during infusion.
    Siegel RA
    J Pharm Sci; 1986 Jun; 75(6):627-8. PubMed ID: 3735112
    [No Abstract]   [Full Text] [Related]  

  • 58. Practical pharmacokinetic techniques for drug consultation and evaluation. II. A perspective on the renal impaired patient.
    Schumacher GE
    Am J Hosp Pharm; 1973 Sep; 30(9):824-30. PubMed ID: 4582138
    [No Abstract]   [Full Text] [Related]  

  • 59. Pharmacokinetic principles in relation to serum drug sample collections.
    Breland BD; Barnes WP
    South Med J; 1981 Dec; 74(12):1439-42. PubMed ID: 7313731
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bioavailability, clinical effectiveness, and the public interest.
    Levy G
    Pharmacology; 1972; 8(1):33-43. PubMed ID: 4644654
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.